↓ Skip to main content

Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis

Overview of attention for article published in Arquivos de Neuro-Psiquiatria, August 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 504)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
3 news outlets
blogs
1 blog

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis
Published in
Arquivos de Neuro-Psiquiatria, August 2013
DOI 10.1590/0004-282x20130081
Pubmed ID
Authors

Guilherme Sciascia do Olival, Vitor Breseghello Cavenaghi, Vitor Serafim, Rodrigo Barbosa Thomaz, Charles Peter Tilbery

Abstract

This article describes the clinical and radiological evolution of a stable group of patients with relapsing-remitting multiple sclerosis that had their disease-modifying therapy (DMT) withdrawn. Forty patients, which had made continuous use of one immunomodulator and had remained free of disease for at least 5 years, had their DMT withdrawn and were observed from 13 to 86 months. Out of the followed patients, 4 (10%) patients presented with new attacks. In addition to these patients, 2 (5%) patients had new lesions revealed by magnetic resonance imaging that did not correspond to clinical attacks. Despite these results, the difficult decision to withdraw medication requires careful analysis. Withdrawal, however, should not be viewed as simply the suspension of treatment because these patients should be evaluated periodically, and the immunomodulators should be readily reintroduced if new attacks occur. Nonetheless, medication withdrawal is an option for a select group of patients.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 4%
Unknown 25 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 19%
Other 5 19%
Researcher 4 15%
Student > Ph. D. Student 4 15%
Student > Postgraduate 2 8%
Other 4 15%
Unknown 2 8%
Readers by discipline Count As %
Medicine and Dentistry 11 42%
Neuroscience 4 15%
Agricultural and Biological Sciences 2 8%
Psychology 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 2 8%
Unknown 4 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2017.
All research outputs
#425,241
of 11,357,652 outputs
Outputs from Arquivos de Neuro-Psiquiatria
#4
of 504 outputs
Outputs of similar age
#6,605
of 142,110 outputs
Outputs of similar age from Arquivos de Neuro-Psiquiatria
#1
of 6 outputs
Altmetric has tracked 11,357,652 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 504 research outputs from this source. They receive a mean Attention Score of 2.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 142,110 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them